Updated Jul 16, 2026
Bhatt Padmanabh P. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $6.18M.
Padmanabh P. Bhatt is a corporate executive currently serving as the Senior Vice President of Intellectual Property and Chief Scientific Officer at Supernus Pharmaceuticals, Inc. He has been involved in the pharmaceutical industry, focusing on the development of treatments for central nervous system diseases.
| Role | Sr. VP of IP, CSO |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 412 | $50.48 | $21K |
| 2026-03-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 6.8K | $49.55 | $339K |
| 2026-03-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | M — Option exercise [10b5-1] | 7.2K | $39.40 | $286K |
| 2026-03-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 22.3K | $50.73 | $1.13M |
| 2026-03-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 27.7K | $49.95 | $1.38M |
| 2026-03-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | M — Option exercise [10b5-1] | 15.0K | $38.60 | $579K |
| 2026-03-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | M — Option exercise [10b5-1] | 12.2K | $36.75 | $450K |
| 2026-03-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | M — Option exercise [10b5-1] | 22.8K | $39.40 | $896K |
| 2026-03-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 15.9K | $50.49 | $802K |
| 2026-03-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 34.1K | $50.18 | $1.71M |
| 2026-03-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | M — Option exercise [10b5-1] | 5.0K | $27.94 | $140K |
| 2026-03-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | M — Option exercise [10b5-1] | 18.0K | $32.20 | $580K |
| 2026-03-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | M — Option exercise [10b5-1] | 4.2K | $29.61 | $126K |
| 2026-03-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | M — Option exercise [10b5-1] | 22.8K | $36.75 | $836K |
| 2026-02-26 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 650 | $50.69 | $33K |
| 2026-02-26 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | A — Grant or award | 1.2K | $0.00 | |
| 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 646 | $50.86 | $33K |
| 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | A — Grant or award | 1.2K | $0.00 | |
| 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 354 | $50.86 | $18K |
| 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | A — Grant or award | 750 | $0.00 |
Padmanabh P. Bhatt is a corporate executive currently serving as the Senior Vice President of Intellectual Property and Chief Scientific Officer at Supernus Pharmaceuticals, Inc. He has been involved in the pharmaceutical industry, focusing on the development of treatments for central nervous system diseases.…
Recorded transactions: 0 open-market purchases () and 8 open-market sales ($6.18M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bhatt Padmanabh P. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.